2.5. Aberration of CpG Methylation on the Promoter Regions of CYP21A2, KCNH2, KRT5, and MMP7 Genes as Methylation Biomarkers for CMT. This evidence concerns the gene KRT5 and Charcot-Marie-Tooth disease.